Efficacy and Safety of Sirolimus Plus CNI Compared With MMF Plus CNI in ABO-i Kidney Transplant Recipients.
Clinical trial NCT04700709 · UNKNOWN
Trial details
- NCT number
- NCT04700709
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2024-12-01
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.